These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 19332539

  • 1. Inhibition of furin/proprotein convertase-catalyzed surface and intracellular processing by small molecules.
    Komiyama T, Coppola JM, Larsen MJ, van Dort ME, Ross BD, Day R, Rehemtulla A, Fuller RS.
    J Biol Chem; 2009 Jun 05; 284(23):15729-38. PubMed ID: 19332539
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A small-molecule furin inhibitor inhibits cancer cell motility and invasiveness.
    Coppola JM, Bhojani MS, Ross BD, Rehemtulla A.
    Neoplasia; 2008 Apr 05; 10(4):363-70. PubMed ID: 18392131
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization and expression of proprotein convertases in CHO cells: Efficient proteolytic maturation of human bone morphogenetic protein-7.
    Sathyamurthy M, Kim CL, Bang YL, Kim YS, Jang JW, Lee GM.
    Biotechnol Bioeng; 2015 Mar 05; 112(3):560-8. PubMed ID: 25219685
    [Abstract] [Full Text] [Related]

  • 8. Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics.
    Becker GL, Sielaff F, Than ME, Lindberg I, Routhier S, Day R, Lu Y, Garten W, Steinmetzer T.
    J Med Chem; 2010 Feb 11; 53(3):1067-75. PubMed ID: 20038105
    [Abstract] [Full Text] [Related]

  • 9. Proprotein convertase inhibitory activities of flavonoids isolated from Oroxylum indicum.
    Majumdar S, Mohanta BC, Chowdhury DR, Banik R, Dinda B, Basak A.
    Curr Med Chem; 2010 Feb 11; 17(19):2049-58. PubMed ID: 20423311
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases.
    Becker GL, Lu Y, Hardes K, Strehlow B, Levesque C, Lindberg I, Sandvig K, Bakowsky U, Day R, Garten W, Steinmetzer T.
    J Biol Chem; 2012 Jun 22; 287(26):21992-2003. PubMed ID: 22539349
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity.
    Srour N, Lebel A, McMahon S, Fournier I, Fugère M, Day R, Dubois CM.
    FEBS Lett; 2003 Nov 20; 554(3):275-83. PubMed ID: 14623079
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anthrax toxin requires ZDHHC5-mediated palmitoylation of its surface-processing host enzymes.
    Sergeeva OA, van der Goot FG.
    Proc Natl Acad Sci U S A; 2019 Jan 22; 116(4):1279-1288. PubMed ID: 30610172
    [Abstract] [Full Text] [Related]

  • 18. The proprotein convertases furin and PACE4 play a significant role in tumor progression.
    Bassi DE, Mahloogi H, Klein-Szanto AJ.
    Mol Carcinog; 2000 Jun 22; 28(2):63-9. PubMed ID: 10900462
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thrombin activation of protein C requires prior processing by a liver proprotein convertase.
    Essalmani R, Susan-Resiga D, Guillemot J, Kim W, Sachan V, Awan Z, Chamberland A, Asselin MC, Ly K, Desjardins R, Day R, Prat A, Seidah NG.
    J Biol Chem; 2017 Jun 23; 292(25):10564-10573. PubMed ID: 28468828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.